EIGR - Eiger BioPharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
No. of Analysts6656
Avg. Estimate-0.8-0.78-1.58-2.15
Low Estimate-1.1-0.91-2.83-2.97
High Estimate-0.7-0.68-0.72-0.9
Year Ago EPS-0.9-0.75-3.08-1.58
Revenue EstimateCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
No. of Analysts4455
Avg. Estimate620k620k24.98M50.91M
Low EstimateN/AN/A1.18M8.56M
High Estimate2.5M2.5M58.5M132.4M
Year Ago SalesN/AN/AN/A24.98M
Sales Growth (year/est)N/AN/AN/A103.80%
Earnings History3/30/20196/29/20199/29/201912/30/2019
EPS Est.-0.95-0.74-0.75-0.43
EPS Actual-0.9-0.75-0.76-0.68
Difference0.05-0.01-0.01-0.25
Surprise %5.30%-1.40%-1.30%-58.10%
EPS TrendCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
Current Estimate-0.8-0.78-1.58-2.15
7 Days Ago-0.69-0.66-1.58-2.15
30 Days Ago-0.81-0.78-1.77-1.95
60 Days Ago-0.82-0.83-1.92-1.68
90 Days Ago-0.82-0.83-1.92-1.68
EPS RevisionsCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days11N/AN/A
Growth EstimatesEIGRIndustrySectorS&P 500
Current Qtr.11.10%N/AN/A-0.34
Next Qtr.-4.00%N/AN/A-0.12
Current Year48.70%N/AN/A-0.18
Next Year-36.10%N/AN/A0.26
Next 5 Years (per annum)N/AN/AN/A0.04
Past 5 Years (per annum)N/AN/AN/AN/A